Deligoparin sodium

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDeligoparin sodium
Drug Alias NameOP 2000Deligoparin sodium (USAN Rec INN)OP-2000
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOpocrin Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncara Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A